Rett syndrome: A complex disorder with simple roots

Nature Reviews Genetics

Volumn 16, Issue 5, 2015, Pages 261-274

  Lyst, Matthew J ^a   Bird, Adrian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; DNA; MECP2 PROTEIN, HUMAN; MECP2 PROTEIN, MOUSE; PROTEIN BINDING; TRANSACTIVATOR PROTEIN;

DNA BINDING; DNA METHYLATION; EMBRYONIC STEM CELL; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FUNGUS MUTATION; GENE EXPRESSION REGULATION; HUMAN; MISSENSE MUTATION; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; RETROPOSON; RETT SYNDROME; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; BRAIN; CHEMISTRY; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; MUTATION; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DNA; GENE EXPRESSION REGULATION; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, KNOCKOUT; MODELS, NEUROLOGICAL; MUTATION; NEURONS; PROTEIN BINDING; RETT SYNDROME; TRANS-ACTIVATORS;

EID: 84928207237     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg3897     Document Type: Review

References (149)

1. Rett A. [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. Wien. Med. Wochenschr. 116, 723-726 (in German) (1966
2. Hagberg B., Aicardi J., Dias K. & Ramos O. A progressive syndrome of autism dementia ataxia and loss of purposeful hand use in girls: Rett"s syndrome: report of 35 cases. Ann. Neurol. 14, 471-479 (1983
3. Neul J. L., et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann. Neurol. 68, 944-950 (2010
4. Percy A. K., et al. Rett syndrome diagnostic criteria: lessons from the Natural History Study. Ann. Neurol. 68, 951-955 (2010
5. Armstrong D., Dunn J. K., Antalffy B. & Trivedi R. Selective dendritic alterations in the cortex of Rett syndrome. J. Neuropathol. Exp. Neurol. 54, 195-201 (1995
6. Trappe R., et al. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am. J. Hum. Genet. 68, 1093-1101 (2001
7. Villard L. MECP2 mutations in males. J. Med. Genet. 44, 417-423 (2007
8. Topçu M., et al. Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur. J. Hum. Genet. 10, 77-81 (2002
9. Schwartzman J. S., Bernardino A., Nishimura A., Gomes R. R. & Zatz M. Rett syndrome in a boy with a 47, XXY karyotype confirmed by a rare mutation in the MECP2 gene. Neuropediatrics 32, 162-164 (2001
10. Amir R. E., et al. Rett syndrome is caused by mutations in X linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet. 23, 185-188 (1999
11. Kriaucionis S. & Bird A. The major form of MeCP2 has a novel N terminus generated by alternative splicing. Nucleic Acids Res. 32, 1818-1823 (2004
12. Mnatzakanian G. N., et al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nature Genet. 36, 339-341 (2004
13. Guy J., Hendrich B., Holmes M., Martin J. E. & Bird A. A mouse Mecp2 null mutation causes neurological symptoms that mimic Rett syndrome. Nature Genet. 27, 322-326 (2001
14. Chen R. Z., Akbarian S., Tudor M. & Jaenisch R. Deficiency of methyl-CpG binding protein 2 in CNS neurons results in a Rett-like phenotype in mice. Nature Genet. 27, 327-331 (2001
15. Marchetto M. C. N., et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143, 527-539 (2010
16. Li Y., et al. Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell 13, 446-458 (2013
17. Yazdani M., et al. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons. Stem Cells 30, 2128-2139 (2012
18. Lyst M. J., et al. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co repressor. Nature Neurosci. 16, 898-902 (2013
19. Heckman L. D., Chahrour M. H. & Zoghbi H. Y. Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice. eLife 3, e02676 (2014
20. Baker S. A., et al. An AT hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell 152, 984-996 (2013
21. Luikenhuis S., Giacometti E., Beard C. F. & Jaenisch R. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl Acad. Sci. USA 101, 6033-6038 (2004
22. Akbarian S., et al. Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol. Dis. 8, 784-791 (2001
23. Shahbazian M. D., Antalffy B., Armstrong D. L. & Zoghbi H. Y. Insight into Rett syndrome: MeCP2 levels display tissue-and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 11, 115-124 (2002
24. Skene P. J., et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 37, 457-468 (2010
25. Mullaney B. C., Johnston M. V. & Blue M. E. Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience 123, 939-949 (2004
26. Jung B. P., et al. The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J. Neurobiol. 55, 86-96 (2003
27. Guy J., Gan J., Selfridge J., Cobb S. & Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143-1147 (2007
28. Cheval H., et al. Postnatal inactivation reveals enhanced requirement for MeCP2 at distinct age windows. Hum. Mol. Genet. 21, 3806-3814 (2012
29. McGraw C. M., Samaco R. C. & Zoghbi H. Y. Adult neural function requires MeCP2. Science 333, 186 (2011
30. Nguyen M. V. C., et al. MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J. Neurosci. 32, 10021-10034 (2012
31. Lioy D. T., et al. A role for glia in the progression of Rett"s syndrome. Nature 475, 497-500 (2011
32. Ballas N., Lioy D. T., Grunseich C. & Mandel G. Non-cell autonomous influence of MeCP2 deficient glia on neuronal dendritic morphology. Nature Neurosci. 12, 311-317 (2009
33. Nguyen M. V. C., et al. Oligodendrocyte lineage cells contribute unique features to Rett syndrome neuropathology. J. Neurosci. 33, 18764-18774 (2013
34. Derecki N. C., et al. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484, 105-109 (2012
35. Gemelli T., et al. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol. Psychiatry 59, 468-476 (2006
36. Chao H. T., et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468, 263-269 (2010
37. Ben-Shachar S., Chahrour M., Thaller C., Shaw C. A. & Zoghbi H. Y. Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum. Mol. Genet. 18, 2431-2442 (2009
38. Sugino K., et al. Cell-type-specific repression by methyl-CpG-binding protein 2 is biased toward long genes. J. Neurosci. 34, 12877-12883 (2014
39. Kron M., et al. Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits including key nodes in the default mode network that are reversed with ketamine treatment. J. Neurosci. 32, 13860-13872 (2012
40. Lewis J. D., et al. Purification sequence and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905-914 (1992
41. Nan X., Meehan R. R. & Bird A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. 21, 4886-4892 (1993
42. Nan X., Tate P., Li E. & Bird A. DNA methylation specifies chromosomal localization of MeCP2. Mol. Cell. Biol. 16, 414-421 (1996
43. Kumar A., et al. Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. J. Cell Sci. 121, 1128-1137 (2008
44. Schmiedeberg L., Skene P., Deaton A. & Bird A. A temporal threshold for formaldehyde crosslinking and fixation. PLoS ONE 4, e4636 (2009
45. Gregory R. I., et al. DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpn and U2af1 rs1. Mol. Cell. Biol. 21, 5426-5436 (2001
46. Guo J. U., et al. Distribution recognition and regulation of non-CpG methylation in the adult mammalian brain. Nature Neurosci. 17, 215-222 (2014
47. Lister R., et al. Global epigenomic reconfiguration during mammalian brain development. Science 341, 1237905 (2013
48. Ohki I., et al. Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell 105, 487-497 (2001
49. Ho, K. L., et al. MeCP2 binding to DNA depends upon hydration at methyl-CpG. Mol. Cell 29, 525-531 (2008
50. Mellén M., Ayata P., Dewell S., Kriaucionis S. & Heintz N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151, 1417-1430 (2012
51. Spruijt C. G., et al. Dynamic readers for 5-(hydroxy) methylcytosine and its oxidized derivatives. Cell 152, 1146-1159 (2013
52. Frauer C., et al. Recognition of 5 hydroxymethylcytosine by the Uhrf1 SRA domain. PLoS ONE 6, e21306 (2011
53. Hashimoto H., et al. Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res. 40, 4841-4849 (2012
54. Khrapunov S., et al. Unusual characteristics of the DNA binding domain of epigenetic regulatory protein MeCP2 determine its binding specificity. Biochemistry 53, 3379-3391 (2014
55. Valinluck V., et al. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32, 4100-4108 (2004
56. Kriaucionis S. & Heintz N. The nuclear DNA base 5 hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929-930 (2009
57. Szulwach K. E., et al. 5 hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nature Neurosci. 14, 1607-1616 (2011
58. Von Kries J. P., Buhrmester H. & Strätling W. H. A matrix/scaffold attachment region binding protein: identification purification and mode of binding. Cell 64, 123-135 (1991
59. Weitzel J. M., Buhrmester H. & Strätling W. H. Chicken MAR-binding protein ARBP is homologous to rat methyl-CpG-binding protein MeCP2. Mol. Cell. Biol. 17, 5656-5666 (1997
60. Ballestar E., Yusufzai T. M. & Wolffe A. P. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry 39, 7100-7106 (2000
61. Yusufzai T. M. & Wolffe A. P. Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res. 28, 4172-4179 (2000
62. Baubec T., Ivánek R., Lienert F. & Schübeler D. Methylation-dependent and -independent genomic targeting principles of the MBD protein family. Cell 153, 480-492 (2013
63. Free A., et al. DNA recognition by the methyl-CpG binding domain of MeCP2. J. Biol. Chem. 276, 3353-3360 (2001
64. Kudo S., et al. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. J. Med. Genet. 40, 487-493 (2003
65. Georgel P. T., et al. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem. 278, 32181-32188 (2003
66. Adams V. H., McBryant S. J., Wade P. A., Woodcock C. L. & Hansen J. C. Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein MeCP2. J. Biol. Chem. 282, 15057-15064 (2007
67. Ghosh R. P., et al. Unique physical properties and interactions of the domains of methylated DNA binding protein 2. Biochemistry 49, 4395-4410 (2010
68. Nikitina T., et al. MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome. J. Biol. Chem. 282, 28237-28245 (2007
69. Thambirajah A. A., et al. MeCP2 binds to nucleosome free (linker DNA) regions and to H3K9/H3K27 methylated nucleosomes in the brain. Nucleic Acids Res. 40, 2884-2897 (2012
70. Goffin D., et al. Rett syndrome mutation MeCP2 T158A disrupts DNA binding protein stability and ERP responses. Nature Neurosci. 15, 274-283 (2011
71. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21 (2002
72. Nan X., Campoy F. J. & Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88, 471-481 (1997
73. Nan X., et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389 (1998
74. Jones P. L., et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genet. 19, 187-191 (1998
75. Kokura K., et al. The Ski protein family is required for MeCP2 mediated transcriptional repression. J. Biol. Chem. 276, 34115-34121 (2001
76. Stancheva I., Collins A. L., Van den Veyver I. B., Zoghbi H. & Meehan R. R. A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Mol. Cell 12, 425-435 (2003
77. Kudo S. Methyl-CpG-binding protein MeCP2 represses Sp1 activated transcription of the human leukosialin gene when the promoter is methylated. Mol. Cell. Biol. 18, 5492-5499 (1998
78. Muotri A. R., et al. L1 retrotransposition in neurons is modulated by MeCP2. Nature 468, 443-446 (2010
79. Robinson L., et al. Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. Brain 135, 2699-2710 (2012
80. Lang M., et al. Rescue of behavioral and EEG deficits in male and female Mecp2 deficient mice by delayed Mecp2 gene reactivation. Hum. Mol. Genet. 23, 303-318 (2014
81. Tudor M., Akbarian S., Chen R. Z. & Jaenisch R. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl Acad. Sci. USA 99, 15536-15541 (2002
82. Chahrour M., et al. MeCP2, a key contributor to neurological disease activates and represses transcription. Science 320, 1224-1229 (2008
83. Ficz G., et al. Dynamic regulation of 5 hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473, 398-402 (2011
84. Wu, H., et al. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 473, 389-393 (2011
85. Wang Z., et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 138, 1019-1031 (2009
86. Ricciardi S., et al. Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum. Mol. Genet. 20, 1182-1196 (2011
87. Shahbazian M. D. & Zoghbi H. Y. Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am. J. Hum. Genet. 71, 1259-1272 (2002
88. Shin J., Ming G. L. & Song H. By hook or by crook: multifaceted DNA-binding properties of MeCP2. Cell 152, 940-942 (2013
89. Brero A., et al. Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation. J. Cell Biol. 169, 733-743 (2005
90. Horike S., Cai S., Miyano M., Cheng J. F. & Kohwi-Shigematsu T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nature Genet. 37, 31-40 (2005
91. Nikitina T., et al. Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. Mol. Cell. Biol. 27, 864-877 (2007
92. Ghosh R. P., Horowitz-Scherer R. A., Nikitina T., Shlyakhtenko L. S. & Woodcock C. L. MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites. Mol. Cell. Biol. 30, 4656-4670 (2010
93. Jeffery L. & Nakielny S. Components of the DNA methylation system of chromatin control are RNA-binding proteins. J. Biol. Chem. 279, 49479-49487 (2004
94. Young J. I., et al. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl Acad. Sci. USA 102, 17551-17558 (2005
95. Maunakea A. K., Chepelev I., Cui K. & Zhao K. Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res. 23, 1256-1269 (2013
96. Cheng T. L., et al. MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/Drosha complex. Dev. Cell 28, 547-560 (2014
97. Samaco R. C., et al. Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome. Nature Genet. 44, 206-211 (2012
98. Chang Q., Khare G., Dani V., Nelson S. & Jaenisch R. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49, 341-348 (2006
99. Kline D. D., Ogier M., Kunze D. L. & Katz D. M. Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2 null mice. J. Neurosci. 30, 5303-5310 (2010
100. Buchovecky C. M., et al. A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome. Nature Genet. 45, 1013-1020 (2013
101. Jordan C., Li H. H., Kwan H. C. & Francke U. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med. Genet. 8, 36 (2007
102. Christodoulou J., Grimm A., Maher T. & Bennetts B. RettBASE: the IRSA MECP2 variation database -a new mutation database in evolution. Hum. Mutat. 21, 466-472 (2003
103. Kerr B., et al. Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes. Eur. J. Hum. Genet. 20, 69-76 (2012
104. Yasui D. H., et al. Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome. Hum. Mol. Genet. 23, 2447-2458 (2014
105. Shahbazian M. D., et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35, 243-254 (2002
106. Bebbington A., et al. Updating the profile of C terminal MECP2 deletions in Rett syndrome. J. Med. Genet. 47, 242-248 (2010
107. Cuddapah V. A., et al. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. J. Med. Genet. 51, 152-158 (2014
108. Neul J. L., et al. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 70, 1313-1321 (2008
109. Cheadle J. P., et al. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum. Mol. Genet. 9, 1119-1129 (2000
110. Obata K., et al. Mutation analysis of the methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome. J. Med. Genet. 37, 608-610 (2000
111. Nan X., et al. Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc. Natl Acad. Sci. USA 104, 2709-2714 (2007
112. Agarwal N., et al. MeCP2 Rett mutations affect large scale chromatin organization. Hum. Mol. Genet. 20, 4187-4195 (2011
113. Kriaucionis S., et al. Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol. Cell. Biol. 26, 5033-5042 (2006
114. Chao H. T., Zoghbi H. Y. & Rosenmund C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56, 58-65 (2007
115. Meins M., et al. Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J. Med. Genet. 42, e12 (2005
116. Van Esch H., et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet. 77, 442-453 (2005
117. Collins A. L., et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13, 2679-2689 (2004
118. Kerr B., Alvarez-Saavedra M., Sáez M. A., Saona A. & Young J. I. Defective body-weight regulation motor control and abnormal social interactions in Mecp2 hypomorphic mice. Hum. Mol. Genet. 17, 1707-1717 (2008
119. Samaco R. C., et al. A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Hum. Mol. Genet. 17, 1718-1727 (2008
120. Han K., et al. Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR 483 5p. Genes Dev. 27, 485-490 (2013
121. Klein M. E., et al. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nature Neurosci. 10, 1513-1514 (2007
122. Ebert D. H. & Greenberg M. E. Activity-dependent neuronal signalling and autism spectrum disorder. Nature 493, 327-337 (2013
123. Chen W. G., et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302, 885-889 (2003
124. Martinowich K., et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302, 890-893 (2003
125. Zhou Z., et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription dendritic growth and spine maturation. Neuron 52, 255-269 (2006
126. Tao J., et al. Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc. Natl Acad. Sci. USA 106, 4882-4887 (2009
127. Ebert D. H., et al. Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. Nature 499, 341-345 (2013
128. Cohen S., et al. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72-85 (2011
129. Li H., Zhong X., Chau K. F., Williams E. C. & Chang Q. Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis LTP and spatial memory. Nature Neurosci. 14, 1001-1008 (2011
130. Fyffe S. L., et al. Deletion of Mecp2 in Sim1 expressing neurons reveals a critical role for MeCP2 in feeding behavior aggression and the response to stress. Neuron 59, 947-958 (2008
131. Wang X., Lacza Z., Sun Y. E. & Han W. Leptin resistance and obesity in mice with deletion of methyl-CpG-binding protein 2 (MeCP2) in hypothalamic pro-opiomelanocortin (POMC) neurons. Diabetologia 57, 236-245 (2014
132. Samaco R. C., et al. Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc. Natl Acad. Sci. USA 106, 21966-21971 (2009
133. Goffin D., Brodkin E. S., Blendy J. A., Siegel S. J. & Zhou Z. Cellular origins of auditory event-related potential deficits in Rett syndrome. Nature Neurosci. 17, 804-806 (2014
134. Zhang W., Peterson M., Beyer B., Frankel W. N. & Zhang Z. Loss of MeCP2 from forebrain excitatory neurons leads to cortical hyperexcitation and seizures. J. Neurosci. 34, 2754-2763 (2014
135. Ward C. S., et al. MeCP2 is critical within HoxB1 derived tissues of mice for normal lifespan. J. Neurosci. 31, 10359-10370 (2011
136. Adachi M., Autry A. E., Covington H. E. & Monteggia L. M. MeCP2 mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome. J. Neurosci. 29, 4218-4227 (2009
137. Kernohan K. D., et al. ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain. Dev. Cell 18, 191-202 (2010
138. Chatr-Aryamontri A., et al. The BioGRID interaction database: 2013 update. Nucleic Acids Res. 41, D816-D823 (2013
139. McFarland K. N., et al. MeCP2: a novel Huntingtin interactor. Hum. Mol. Genet. 23, 1036-1044 (2014
140. Subbanna S., et al. Ethanol-induced acetylation of histone at G9a exon1 and G9a mediated histone H3 dimethylation leads to neurodegeneration in neonatal mice. Neuroscience 258, 422-432 (2014
141. Long S. W., Ooi J. Y. Y., Yau P. M. & Jones P. L. A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing. Biosci. Rep. 31, 333-343 (2011
142. Khoshnan A. & Patterson P. H. Elevated IKKα accelerates the differentiation of human neuronal progenitor cells and induces MeCP2 dependent BDNF expression. PLoS ONE 7, e41794 (2012
143. Becker A., et al. Direct homo-and hetero-interactions of MeCP2 and MBD2. PLoS ONE 8, e53730 (2013
144. Sephton C. F., et al. Identification of neuronal RNA targets of TDP 43 containing ribonucleoprotein complexes. J. Biol. Chem. 286, 1204-1215 (2011
145. Cartron P. F., et al. Identification of TET1 partners that control its DNA-demethylating function. Genes Cancer 4, 235-241 (2013
146. Leoh L. S., et al. The stress oncoprotein LEDGF/p75 interacts with the methyl CpG binding protein MeCP2 and influences its transcriptional activity. Mol. Cancer Res. 10, 378-391 (2012
147. Xue J., Wijeratne S. S. K. & Zempleni J. Holocarboxylase synthetase synergizes with methyl CpG binding protein 2 and DNA methyltransferase 1 in the transcriptional repression of long-terminal repeats. Epigenetics 8, 504-511 (2013
148. Murphy D. M., et al. Co localization of the oncogenic transcription factor MYCN and the DNA methyl binding protein MeCP2 at genomic sites in neuroblastoma. PLoS ONE 6, e21436 (2011
149. Gabel H. W., et al. Disruption of DNA methylation-dependent long gene repression in Rett syndrome. Nature (in the press